Literature DB >> 25951725

High grade serous ovarian carcinoma with serous tubal intraepithelial carcinoma in a case presented with atypical glandular cell favor neoplasm cervical cytology and dermatomyositis.

Mun-Kun Hong1, Ming-Hsun Lee2, Dah-Ching Ding3, Sung-Chao Chu4, Tang-Yuan Chu5.   

Abstract

OBJECTIVE: This report describes a case of serous ovarian carcinoma with occult serous tubal intraepithelial carcinoma (STIC), which presented as atypical glandular cells favor neoplasia (AGC-FN) with Pap cytology and dermatomyositis. CASE REPORT: A 48-year-old woman presented with symptoms of dermatomyositis. An AGC-FN result from a Pap smear, with an absence of a cervical or endometrial lesion was noted. After cancer surveillance, ovarian high grade serous carcinoma associated with serous tubal intraepithelial carcinoma was diagnosed. Two weeks following surgical excision of the carcinoma, dramatic remission of the dermatomyositis symptoms was evident.
CONCLUSION: The patient had serous carcinoma of the ovary with tubal STIC, which presented as dermatomyositis. The AGC-FN identified from a Pap smear hinted at a diagnosis of ovarian carcinoma. These presentations point to an occult malignancy in the genital tract and demand careful diagnostic workup.
Copyright © 2015. Published by Elsevier B.V.

Entities:  

Keywords:  atypical glandular cell; dermatomyositis; p53 signature; serous tubal intraepithelial carcinoma

Mesh:

Year:  2015        PMID: 25951725     DOI: 10.1016/j.tjog.2013.07.004

Source DB:  PubMed          Journal:  Taiwan J Obstet Gynecol        ISSN: 1028-4559            Impact factor:   1.705


  2 in total

Review 1.  Paraneoplastic antigens as biomarkers for early diagnosis of ovarian cancer.

Authors:  Madhumita Chatterjee; Laura C Hurley; Michael A Tainsky
Journal:  Gynecol Oncol Rep       Date:  2017-06-15

2.  Paraneoplastic myositis secondary to poorly differentiated serous carcinoma of ovarian/tubal origin.

Authors:  Zachary Raizman; Boshra Hosseini; Sarah Kean; Alon D Altman
Journal:  Gynecol Oncol Rep       Date:  2017-04-05
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.